Business Description
BBS-Bioactive Bone Substitutes PLC
ISIN : FI4000260583
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.47 | |||||
Debt-to-EBITDA | -1.76 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 12.3 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 15.2 | |||||
3-Year Book Growth Rate | -28.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 19.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.2 | |||||
9-Day RSI | 55.31 | |||||
14-Day RSI | 46.57 | |||||
6-1 Month Momentum % | -77.43 | |||||
12-1 Month Momentum % | -85.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.39 | |||||
Quick Ratio | 0.39 | |||||
Cash Ratio | 0.37 | |||||
Days Payable | 3501.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.9 | |||||
Shareholder Yield % | -74.15 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -80.47 | |||||
ROA % | -34.74 | |||||
ROIC % | -32.42 | |||||
3-Year ROIIC % | -481.33 | |||||
ROC (Joel Greenblatt) % | -328.32 | |||||
ROCE % | -40.79 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.35 | |||||
EV-to-EBIT | -1.97 | |||||
EV-to-EBITDA | -2.11 | |||||
EV-to-FCF | -2.13 | |||||
Earnings Yield (Greenblatt) % | -50.86 | |||||
FCF Yield % | -158.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BBS-Bioactive Bone Substitutes PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.179 | ||
Beta | -0.13 | ||
Volatility % | 74.59 | ||
14-Day RSI | 46.57 | ||
14-Day ATR (€) | 0.009789 | ||
20-Day SMA (€) | 0.05978 | ||
12-1 Month Momentum % | -85.36 | ||
52-Week Range (€) | 0.04 - 0.642481 | ||
Shares Outstanding (Mil) | 27.94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BBS-Bioactive Bone Substitutes PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BBS-Bioactive Bone Substitutes PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
BBS-Bioactive Bone Substitutes PLC Frequently Asked Questions
What is BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH)'s stock price today?
When is next earnings date of BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH)?
Does BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |